|Message:||Recipients' Email:||Type address separated by commas|
|Your Email:||Enter the characters shown in the image.|
|Send me a copy:|
. The diagnostics sector was re-rated last year on expectations of growth in the market share from unorganised players, as well as scope for expanding into smaller towns. .
While stocks, such as Dr Lal Pathlabs, have given handsome returns, at 73 per cent Metropolis Healthcare returns in 2019 was the best among the listed players in the segment. . A key strength of the firm, which gets three quarters of its revenues from west and south India ...
Read the full text business-standard